Opus Genetics (IRD) Net Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -296.63% |
| Dec 31, 2025 | 5.33% |
| Sep 30, 2025 | -135.23% |
| Jun 30, 2025 | 9.45% |
| Mar 31, 2025 | 76.68% |
| Dec 31, 2024 | -366.85% |
| Sep 30, 2024 | 3.08% |
| Jun 30, 2024 | -9.27% |
| Mar 31, 2024 | -48.20% |
| Dec 31, 2023 | -186.23% |
| Sep 30, 2023 | 212.09% |
| Jun 30, 2023 | 14.33% |
| Mar 31, 2023 | -117.06% |
| Dec 31, 2022 | 849.08% |
| Sep 30, 2022 | 8.04% |
| Jun 30, 2022 | 25.29% |
| Mar 31, 2022 | -4.47% |
| Dec 31, 2021 | -49.24% |
| Sep 30, 2021 | 40.72% |
| Jun 30, 2021 | 81.71% |
| Mar 31, 2021 | -108.85% |
| Dec 31, 2020 | -1,396.79% |
| Sep 30, 2020 | 22.19% |
| Jun 30, 2020 | 48.06% |
| Mar 31, 2020 | -616.81% |
| Dec 31, 2019 | 130.50% |
| Sep 30, 2019 | 20.49% |
| Jun 30, 2019 | -5.18% |
| Mar 31, 2019 | 24.82% |
| Dec 31, 2018 | 41.62% |
| Sep 30, 2018 | -39.09% |
| Jun 30, 2018 | -84.99% |
| Mar 31, 2018 | 42.24% |
| Dec 31, 2017 | -246.07% |
| Sep 30, 2017 | -209.61% |
| Jun 30, 2017 | 104.38% |
| Mar 31, 2017 | -4,012.60% |
| Dec 31, 2016 | 81.67% |
| Sep 30, 2016 | -62.36% |
| Jun 30, 2016 | 57.44% |
| Mar 31, 2016 | -45.47% |
| Dec 31, 2015 | 29.17% |
| Sep 30, 2015 | -24.50% |
| Jun 30, 2015 | 24.29% |
| Mar 31, 2015 | -93.28% |
| Dec 31, 2014 | -15.99% |
| Sep 30, 2014 | -1,079.85% |
| Jun 30, 2014 | 101.33% |
| Mar 31, 2014 | -436.85% |
| Dec 31, 2013 | -27.03% |
| Sep 30, 2013 | 31.13% |
| Jun 30, 2013 | -103.17% |
| Mar 31, 2013 | -2,661.72% |
| Dec 31, 2012 | 98.15% |
| Sep 30, 2012 | -186.75% |
| Jun 30, 2012 | 51.28% |
| Mar 31, 2012 | -649.68% |
| Dec 31, 2011 | 126.50% |
| Sep 30, 2011 | 74.79% |
| Jun 30, 2011 | -31.39% |
| Mar 31, 2011 | -69.95% |
| Dec 31, 2010 | -1,292.53% |
| Sep 30, 2010 | 106.09% |